A growing share of Americans worry about affording prescription drugs, with 59% saying they are at least somewhat concerned — the highest level recorded since 2018, according to a March 13 KFF poll.
About 22% of respondents said they are “very worried” about prescription drug costs. Majorities across political parties also said the government should do more to regulate drug prices, with 72% saying there is not as much regulation as there should be and 13% saying there is too much.
The survey was conducted Feb. 24 to March 2, 2026, among 1,343 U.S. adults. Support for increased regulation spans parties, including 77% of Democrats, 72% of independents and 68% of Republicans.
The poll also examined awareness of TrumpRx, a drug discount website launched Feb. 5. Among people who take prescription drugs, 35% said they had heard at least “some” about the site and 7% said they had visited it to compare prices.
Most respondents also said they are skeptical that the administration’s policies will lower drug costs. Fifty-nine percent said it is “not too likely” or “not at all likely” the policies will reduce costs for people like them, compared with 41% who said it is “very” or “somewhat” likely.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
